Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission compared to placebo, consistent with improvements seen in ...
Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNP Current treatment options leave many patients with uncontrolled disease and ...
“We’re humans,” Drew said. “People make mistakes, but if it was on purpose and you knew to take the medicine off the shelf and you never did, then yeah, that’s going to be a very bad answer, because ...
The American Academy of Oral Medicine ... in ulcer pain and duration, while decreases in ulcer frequency and prolongation of remission remain elusive. In limited trials, tetracycline mouth ...